Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Clinical trial NCT00425477 · COMPLETED
Trial details
- NCT number
- NCT00425477
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2016-09-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.